Steven St. Peter
2018
In 2018, Steven St. Peter earned a total compensation of $2.1M as President and CEO at Aratana Therapeutics, a 26% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $247,000 |
|---|---|
| Option Awards | $649,006 |
| Salary | $528,390 |
| Stock Awards | $654,948 |
| Other | $11,000 |
| Total | $2,090,344 |
Peter received $654.9K in stock awards, accounting for 31% of the total pay in 2018.
Peter also received $247K in non-equity incentive plan, $649K in option awards, $528.4K in salary and $11K in other compensation.
Rankings
In 2018, Steven St. Peter's compensation ranked 5,500th out of 14,244 executives tracked by ExecPay. In other words, Peter earned more than 61.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,500 out of 14,244 | 61st |
Division Manufacturing | 2,076 out of 5,765 | 64th |
Major group Chemicals And Allied Products | 765 out of 2,128 | 64th |
Industry group Drugs | 640 out of 1,817 | 65th |
Industry Pharmaceutical Preparations | 493 out of 1,391 | 65th |
Source: SEC filing on April 19, 2019.
Peter's colleagues
We found two more compensation records of executives who worked with Steven St. Peter at Aratana Therapeutics in 2018.